Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/04/2012 | US8323947 Recombinant β-glucosidase variants for production of soluble sugars from cellulosic biomass |
12/04/2012 | US8323931 Hosts and fermentation processes for cellulase production |
12/04/2012 | US8323928 Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease |
12/04/2012 | US8323926 Gene from Hancenula polymorpha capable of controlling unfolded protein response and method for increasing effect of secretion using the same |
12/04/2012 | US8323925 Aβ-binding protein and its peptide derivatives and uses thereof |
12/04/2012 | US8323910 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
12/04/2012 | US8323906 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
12/04/2012 | US8323885 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders |
12/04/2012 | US8323884 Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses |
12/04/2012 | US8323660 Method for identification, isolation and production of antigens to a specific pathogen |
12/04/2012 | US8323654 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules |
12/04/2012 | US8323651 Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof |
12/04/2012 | US8323647 Humanized antibodies against the β-amyloid peptide |
12/04/2012 | US8323646 Engineered anti-IL-13 antibodies, compositions, methods and uses |
12/04/2012 | US8323640 Highly functional enzyme having α-galactosidase activity |
12/04/2012 | US8323634 Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor |
12/04/2012 | CA2532966C Igm production by transformed cells and methods for quantifying said igm production |
12/04/2012 | CA2463879C Glycoprotein compositions |
12/04/2012 | CA2443345C Disease-associated protein |
12/04/2012 | CA2436214C A method of increasing complementarity in a heteroduplex polynucleotide |
12/04/2012 | CA2340304C Multicomponent vaccines |
12/04/2012 | CA2241267C Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods |
12/04/2012 | CA2210484C Composition to ameliorate osteolysis and metastasis |
11/29/2012 | WO2012162277A1 METHOD FOR PREPARING Fc-CONTAINING POLYPEPTIDES HAVING IMPROVED PROPERTIES |
11/29/2012 | WO2012162160A1 Modified glycoproteins |
11/29/2012 | WO2012161956A2 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris |
11/29/2012 | WO2012161024A1 Method for producing recombinant protein, and method for introducing protein |
11/29/2012 | WO2012160678A1 Substance for inhibiting infection by human immunodeficiency virus |
11/29/2012 | WO2012106670A8 Expandable liquid volume in an led bulb |
11/29/2012 | WO2008045970A8 Compositions and methods of using chondroitinase abci mutants |
11/29/2012 | WO2006091470A8 Improved halohydrin dehalogenases and related polynucleotides |
11/29/2012 | US20120302739 Biological products |
11/29/2012 | US20120302738 Recombinant antibody vector |
11/29/2012 | US20120302737 Coiled coil and/or tether containing protein complexes and uses thereof |
11/29/2012 | US20120302731 Protein hydrolysate, polypeptide solution and polypeptide, preparation method and use thereof |
11/29/2012 | US20120302512 Isolated laminin-421 |
11/29/2012 | US20120302496 Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides |
11/29/2012 | US20120302452 Comparative ligand mapping from mhc class i positive cells |
11/29/2012 | US20120301923 Dialysis fermenter-bioreactor with dialysis device |
11/29/2012 | US20120301922 Novel p. pastoris pastoris promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy |
11/29/2012 | US20120301921 Compositions and methods of treating disease with fgfr fusion proteins |
11/29/2012 | US20120301920 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene |
11/29/2012 | US20120301919 Ires mediated multicistronic vectors |
11/29/2012 | US20120301918 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
11/29/2012 | US20120301899 Use of novel markers of pluripotent stem cells |
11/29/2012 | US20120301894 Labeling and detection of post translationally modified proteins |
11/29/2012 | US20120301873 Human long pentraxin 3 expression system and uses thereof |
11/29/2012 | US20120301871 Comparative ligand mapping from mhc positive cells |
11/29/2012 | US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine |
11/29/2012 | US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c |
11/29/2012 | US20120301472 Reagents and treatment methods for autoimmune diseases |
11/29/2012 | US20120301469 amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
11/29/2012 | US20120301462 Compounds |
11/29/2012 | US20120301461 1d05 pcsk9 antagonists |
11/29/2012 | US20120301429 Dac hyp compositions and methods |
11/29/2012 | US20120301395 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor |
11/29/2012 | US20120301394 Targeting and in vivo imaging of tumor-associated macrophages |
11/29/2012 | CA2837000A1 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris |
11/29/2012 | CA2834589A1 Method for preparing fc-containing polypeptides having improved properties |
11/28/2012 | EP2528002A2 Defined glycoprotein products and related methods |
11/28/2012 | EP2527439A2 Compositions and methods related to mRNA translational enhancer elements |
11/28/2012 | EP2527437A1 Novel anti-CD98 antibody |
11/28/2012 | EP2527367A1 Production method |
11/28/2012 | EP2527364A1 Crystalline anti-human IL-12 antibodies |
11/28/2012 | EP2526117A2 Process for preparing fgf-21 with low degree of o-glycosylation |
11/28/2012 | EP2526112A1 Targeted genomic alteration |
11/28/2012 | CN102803500A Immunoregulatory peptides and methods of use |
11/28/2012 | CN102803484A Process for production of protein |
11/28/2012 | CN102803294A Anti-ASCT2 (system ASC amino acid transporter type 2) antibody |
11/28/2012 | CN102803286A Process for production of peptide thioester |
11/28/2012 | CN102802661A Engineered Fc Regions For Site-specific Conjugation |
11/28/2012 | CN102796795A Process method for quickly preparing soybean antioxidant peptide |
11/28/2012 | CN102796794A Preparation method of cantharis toxin |
11/28/2012 | CN102796793A Preparation method of ant toxin |
11/28/2012 | CN102796792A Preparation method for chitterlings membrane protein peptide zinc chelate preparation |
11/28/2012 | CN102796791A Bone morphogenetic protein-2 preparing method |
11/28/2012 | CN102796705A Dac hyp compositions and methods |
11/28/2012 | CN102796680A Streptomyces roseosporus and method for producing daptomycin by utilizing combined precursor |
11/28/2012 | CN102796608A Method for recovering soybean oil and protein in hydrolysate with aqueous enzymatic method |
11/28/2012 | CN102796183A Insecticidal protein, and coding gene and purposes thereof |
11/28/2012 | CN102796182A Insecticidal protein, as well as coding gene and application thereof |
11/28/2012 | CN102796180A Specific basic fibroblast growth factor (bFGF) binding peptide |
11/28/2012 | CN102793921A Methods for treating tweak-related conditions |
11/28/2012 | CN102221586B Preparation method of membrane protein polypeptides for improving detection rate of membrane proteins |
11/28/2012 | CN102002517B Fermentation medium for preparing recombination IL-1ra (Interleukin-1 Receptor Antagonist) and fermentation method thereof |
11/28/2012 | CN101979651B Method for synthesizing nitrosohaemoglobin by enzyme method |
11/28/2012 | CN101978827B Ningnanmycin composition and preparation method thereof |
11/28/2012 | CN101918549B Improved humanized anti-human alpha9-integrin antibody |
11/28/2012 | CN101622345B A novel beta-galactoside-alpha-2,6-sialyltransferase, a geneencoding thereof, and a method for enhancing enzyme activity |
11/28/2012 | CN101139625B Ace inhibitory peptides from plant materials |
11/27/2012 | US8318914 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms |
11/27/2012 | US8318911 Anti-EpCAM antibody and uses thereof |
11/27/2012 | US8318910 IL-13 receptor antibodies |
11/27/2012 | US8318908 Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof |
11/27/2012 | US8318907 Fc variants with altered binding to FcRn |
11/27/2012 | US8318906 EMP2 antibodies and their therapeutic uses |
11/27/2012 | US8318671 Pharmaceutical preparations comprising human proNGF |
11/27/2012 | US8318474 Engineered yeast cells and uses thereof |
11/27/2012 | US8318471 Nitrilases, nucleic acids encoding them and methods for making and using them |
11/27/2012 | US8318457 FSH producing cell clone |